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The deposition of amyloid fibers at the peripheral nervous system can induce motor neuropathy in Familial
Amiloidotic Polyneuropathy (FAP) patients. This produces progressive reductions in functional capacity. The only
treatment for FAP is a liver transplant, followed by aggressive medication that can affect patients’ metabolism. To our
knowledge, there are no data on body fat distribution or comparison between healthy and FAP subjects, which may
be important for clinical assessment and management of this disease. Purpose: To analyze body fat content and
distribution between FAP patients and healthy subjects. Methods: Body fat content and distribution were measured
through Double Energy X-ray Densitometry (DXA) in two groups. Group 1 consisted of 43 Familial Amyloidotic
Polyneuropathy patients (19 males, 32 + 8 Yrs, and 24 females, 37 + 5 yrs), who had liver transplant less than 2
Abstract
Results and Discussion
Healthy subjects showed higher values than FAP patients for abdominal fat mass/ body fat mass ratio (0,09+0,02 vs
0,08+0,02 respectively, p<0,05), abdominal fat mass/trunk fat mass ratio (0,19+0,03 vs 0,17+0,03 respectively, p<0,05)
and visceral abdominal fat/abdominal fat ratio (0,19+0,03 vs 0,17+0,03 respectively, p<0,05).
Healthy subjects showed higher values than FAP patients for: Body Mass Index (24,2+2,3kg/m2 vs 22,3+3,8 kg/m2
respectively, p<0,05), as shown in table 1.
Body fat distribution variables were calculated using ratios between body fat content absolute values of different fat
depots, obtained by DXA. Ratios were registered to the nearest 0,01.
Descriptive statistics were used and t-test was performed to compare results between groups. The level of
significance was set at P<0,05.
Table 3: Body Fat Distribution Variables (Mean ± SD; Min. – Máx.; P value for t test).
months before. Group 2 consisted of 18 healthy subjects of similar age (8 males, 36 + 7 yrs, and 10 females, 39 + 5
yrs). Results: Healthy subjects showed higher values than FAP patients for: BMI (24,2+2,3kg/m2 vs 22,3+3,8 kg/m2
respectively, p<0,05), % trunk BF (26,21+8,34kg vs 20,78+9,05kg respectively, p<0,05), % visceral BF (24,43+7,97%
vs 19,21+9,30% respectively, p<0,05), % abdominal BF (26,63+8,51% vs 20,63+10,35% respectively, p<0,05),
abdominal BF/BF ratio (0,09+0,02 vs 0,08+0,02 respectively, p<0,05) and abdominal BF/trunk BF ratio (0,19+0,03 vs
0,17+0,03 respectively, p<0,05). Conclusion: These results showed that FAP patients soon after liver transplantation
exhibited a healthier body fat profile compared to controls. However, fat content and distribution varied widely in FAP
subjects, suggesting an individualized approach for assessment and intervention rather than general guidelines.
Future research is needed to investigate the long term consequences on body fat following liver transplant in this
population.
Excess body fat or a hazardous fat distribution may be the cause of several metabolic disorders including diabetes,
hypertension and fatty liver [1]. Familial Amiloidotic Polyneuropathy (FAP) is a disease characterized by deposition of
amyloid fibers at the peripheral nervous system and can induce motor neuropathy and progressively reduce
functional capacity [2, 3]. Amiloid fibers in FAP patients are mainly released by the liver. The only treatment for FAP
is a liver transplant, followed by aggressive medication that can affect patients’ metabolism [4, 5]. To our knowledge,
there are no data on body fat distribution or comparison between healthy and FAP subjects, which may be important
for clinical assessment and management of this disease.
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The purpose of this investigation was to analyze body fat content and distribution of FAP patients and to compare
with healthy subjects.
Table 1: Whole Body Composition Variables (Mean ± SD; Min. – Máx.; P value for t test).
These results showed that FAP patients soon after liver transplantation exhibited a healthier body fat profile compared to
controls. However, fat content and distribution varied widely in FAP subjects, suggesting an individualized approach for
assessment and intervention rather than general guidelines. Future research is needed to investigate the long term
consequences on body fat following liver transplant in this population.
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Conclusions
Healthy subjects showed higher values than FAP patients for % trunk fat mass (26,21+8,34kg vs 20,78+9,05kg
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mass (26,63+8,51% vs 20,63+10,35% respectively, p<0,05), as shown in table 2.
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Height was measured to the nearest 0.1 cm, and weight was measured using standard weighing scales (SECA,
Hamburg) to the nearest 100 g, both according to Marfell-jones [6].
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* Difference between the means (p<0.05); ** Difference between the means (p<0.001).
Body fat content were estimated using Dual Energy X-ray Absorptiometry (DXA)
(QDR-Explorer - Hologic, Waltham, MA; Fan bean mode) whole body scans wich
allowed us to access total and regional (trunk fat, appendicular fat, abdominal fat),
absolute and relative, body fat. Absolute values were registered to the nearest
0,01kg and the relative values were registered to the nearest 0,01%. All scans
were made in the morning with the patients in overnight fasting state. Quality
control with spine phantom was made every morning. All procedures, including
placing the patients for the scans, were made according to the user’s guide of the
equipment [7]. All scan analysis were made by the same observer. Each Scan
lasted about 7 minutes.
All Scan were submitted to additional analysis by regions of interest (ROI) to
access fat content of the abdominal region. Regions of interest were determined
as seem in figure 1, according to Kamel et al. [8] and Park et al. [9].
Fig. 1: DXA Scan with
marked Regions of Interest
* Difference between the means of both groups (p<0.05)
